Concepedia

Paulo Henrique de Almeida Rodrigues

PH

Statistics

Publications

2

Citations

41

H-Index

2

Active since

2020

Affiliations

Universidade do Estado do Rio de Janeiro(Current)

Fundação Oswaldo Cruz

Escola Nacional de Saúde Pública

Paulo Henrique de Almeida Rodrigues is an author at Universidade do Estado do Rio de Janeiro specializing in drug acquisition costs, eculizumab therapy, and pharmacoeconomic evaluation.

ORCID

Publications per year

2020–2021

2

Publications

2

The case of eculizumab: litigation and purchases by the Brazilian Ministry of Health

Rosângela Caetano, Paulo Henrique de Almeida Rodrigues, Marilena Corrêa et al. · Revista de Saúde Pública · 2020 · 28 citations · Full text

, , +15

Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab

Rosângela Caetano, Marilena Corrêa, Pedro Villardi et al. · PLoS ONE · 2021 · 13 citations · Full text

, , +17

1–2 of 2